| Vitamin |
Sources |
Daily Requirement |
Action |
Deficiency |
Excess |
Diagnosis |
Treatment |
|
| A |
Green leafy vegetables, carrots, sweet potatoes, liver |
<6 mo: 400 mcg 7 to 12 mo: 500 mcg 1 to 3 y: 300 mcg 4 to 8 y: 400 mcg 9 to 15 y: 600 mcg |
Vision in dim light, bone and tooth growth, epithelium maturation |
Nyctalopia, photophobia, keratomalacia, blindness, impaired growth, follicular hyperkeratosis |
Anorexia, dry skin, painful joints, increased intracranial pressure, headache, vomiting |
Clinical or low plasma retinol levels |
<9 y: 600 to 900 mcg PO q day >9 y: 1,700 mcg/d PO q day until recovery |
| B1 (Thiamine) |
Liver, pork, milk, grains |
<6 mo: 0.2 mg 6 to 12 mo: 0.3 mg 1 to 3 y: 0.5 mg 4 to 8 y: 0.6 mg 9 to 13 y: 0.9 mg >14 y: 1.2 mg |
Part of thiamine pyrophosphate, which is needed for oxidative decarboxylation |
Beriberi, fatigue, cardiac failure, polyneuritis |
None |
Response to thiamine |
10 mg IV/IM/PO for 2 wk; then 5 mg q day for 1 mo |
| Riboflavin (B2) |
Milk, cheese, liver, green leafy vegetables |
Infants: 0.3 to 0.4 mg 1 to 3 y: 0.5 mg 4 to 8 y: 0.6 mg 9 to 13 y: 0.9 mg >14 yr: 1.3 mg |
Part of flavoproteins important for hydrogen transfer |
Blurring of vision, cheilosis |
None |
Urinary riboflavin of <30 mcg/d |
3 to 10 mg PO in divided doses daily |
| Niacin (Nicotinic acid) |
Liver, fish, whole grains, eggs, milk, poultry |
<1 y: 2 to 4 mg 1 to 3 y: 6 mg 4 to 8 y: 8 mg 9 to 13 y: 12 mg >13 y: 16 mg |
Forms NAD and NADP cofactors |
Pellagra (rash, diarrhea, stomatitis, glossitis, mental status changes) |
None |
Clinical and N'methylnicotinamid (NMN) excretion of <0.8 mg/d |
10 to 50 mg PO q 6 h |
| B12 (Cobalamine) |
Fish, eggs, cheese |
0 to 6 mo: 0.4 mcg 6 to 12 mo: 0.5 mcg 1 to 3 y: 0.9 mcg 4 to 8 y: 1.2 mcg 9 to 13 y: 1.8 mcg >13 y: 2.4 mcg |
Maturation of red blood cells |
Juvenile pernicious anemia |
None |
Megaloblastic macrocytic anemia, hypersegmented neutrophils, high lactic dehydrogenase, excessive methylmalonic acid in the urine, serum B12 assays of <150 pg/mL, Schilling test |
100 mcg/d IM for 2 wk; then q week until hematocrit normalizes; then 60 mcg/d IM q mo |
| B6 (Pyridoxine) |
Meat, liver, kidneys |
<6 mo: 0.1 mg 6 to 12 mo: 0.3 mg 1 to 3 y: 0.5 mg 4 to 8 y: 6.0 mg 9 to 13 y: 1.0 mg >13 y: 1.3 mg |
Decarboxylation reactions and transaminations |
Seizures, irritability, sensory ataxia |
Neuropathy |
Whole blood concentration of pyridoxal phosphate |
Seizures: 50 to 100 mg IV or IM |
| Folate |
Cauliflower, green leafy vegetables, yeast, liver, kidney |
<6 mo: 65 mcg 6 to 12 mo: 80 mcg 1 to 3 y: 150 mcg 4 to 8 y: 200 mcg 9 to 13 y: 300 mcg >13 y: 100 mcg |
Maturation of red blood cells and synthesis of nucleic acids |
Megaloblastic anemia, irritability, failure to gain weight |
|
Low serum folate levels of <4 ng/mL, low red blood cell folate levels, elevated serum homocysteine levels with normal methylmalonic acid level |
Infants: 15 mcg/kg per day PO/IM 1 to 13 y: I mg/d followed by 0.1 mg/d until recovery >13 y: 1 mg/d |
| Vitamin D |
Fortified milk, liver oils, sunlight, egg yolks |
<12 mo: 200 IU 1 to 15 y: 200 IU Preterm infants: 400 IU |
Regulates calcium and phosphorus levels, promotes endochondral growth of long bones, mineralization of zone of provisional calcification |
Rickets, tetany, bow legs, poor growth |
Diarrhea, weight loss, calcification of soft tissues |
Low serum calcium, phosphous, and 25 hydroxy-D3; high alkaline phosphatase and urine cyclic AMP; widened bone ends, with cupping and fraying of long bones |
Vitamin D3 150 to 250 mcg (5,000 to 10,000 IU) for 2 to 3 mo. After healing is complete, reduce dose to 10 mcg/d. Or a single-dose regimen of 15,000 mcg (600,000 IU) orally or parenterally |
| Vitamin E (Tocopherol) |
Germ oils, green leafy vegetables |
<6 mo: 4 mg 7 to 12 mo: 5 mg 1 to 3 y: 6 mg 4 to 6 y: 7 mg 9 to 13 y: 11 mg >14 y: 15 mg |
Membrane stabilization, antioxidant |
Red blood cell hemolysis, muscle weakness, double vision |
Nausea, diarrhea, vitamin K antagonism |
Plasma alpha-tocopherol levels <5 mg/L |
15 to 25 mg/kg per day of alpha-tocopherol PO |
| Vitamin K |
Green leafy vegetables, liver |
<6 mo: 2 mcg 7 to 12 mo: 2.5 mcg 1 to 3 y: 30 mcg 4 to 7 y: 55 mcg 9 to 15 y: 60 to 75 mcg |
Prothrombin formation, factors, II, VII, IX, X |
Hemorrhagic manifestations |
Hyperbilirubinemia, hemolytic anemia, kernicterus |
Prolonged prothrombin and partial thromboplastin time, presence of des-gamma- carboxyprothrombin (DCP) in plasma |
2 U first; further doses as needed |
| Vitamin C |
Citrus fruits |
<6 mo: 40 mg 7 to 12 mo: 50 mg 1 to 3 y: 15 mg 4 to 8 y: 25 mg 9 to 13 y: 45 mg >14 y: 75 mg |
Integrity of intercellular material, absorption of iron and folic acid |
Scurvy, poor wound healing |
Oxaluria |
Positive capillary fragility test, ascorbic acid levels <0.1 mg/dL or white blood cell ascorbic acid level 0 to 7 mg/dL, low levels of vitamin C in urine after a test dose of vitamin C, normal bleeding time, widening of the zone of provisional calcification on radiographs of bone ends |
25 mg of ascorbic acid PO q 6 h for 1 wk |